CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-02 | FARRELL PETER C Director | Sale 10b5-1 | −2,000 | $219.74 | $439K | 73,218 |
| 2025-04-01 | Rider Michael J Global General Counsel | Sale 10b5-1 | −64 | $222.86 | $14K | 8,846 |
| 2025-03-10 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $230.36 | $230K | 90,864 |
| 2025-03-10 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise 10b5-1 | +169 | $146.34 | $25K | 9,894 |
| 2025-03-10 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise 10b5-1 | +105 | $211.76 | $22K | 9,999 |
| 2025-03-10 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise 10b5-1 | +3,589 | $146.34 | $525K | 13,588 |
| 2025-03-10 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise 10b5-1 | +5,882 | $211.76 | $1.2M | 19,470 |
| 2025-03-10 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Sale 10b5-1 | −9,745 | $239.31 | $2.3M | 9,725 |
| 2025-03-10 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise · ResMed Common Stock Options 10b5-1 | −169 | 0 | ||
| 2025-03-10 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise · ResMed Common Stock Options 10b5-1 | −105 | 0 | ||
| 2025-03-10 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise · ResMed Common Stock Options 10b5-1 | −5,882 | 0 | ||
| 2025-03-10 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise · ResMed Common Stock Options 10b5-1 | −3,589 | 0 | ||
| 2025-03-07 | Farrell Michael J. Chief Executive Officer | Option exercise 10b5-1 | +8,009 | $101.64 | $814K | 463,481 |
| 2025-03-07 | Farrell Michael J. Chief Executive Officer | Sale 10b5-1 | −8,009 | $229.20 | $1.8M | 455,472 |
| 2025-03-07 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −8,009 | 64,074 | ||
| 2025-03-05 | FARRELL PETER C Director | Sale 10b5-1 | −2,000 | $227.71 | $455K | 75,218 |
| 2025-03-03 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise 10b5-1 | +367 | $211.76 | $78K | 10,092 |
| 2025-03-03 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise 10b5-1 | +3,506 | $146.34 | $513K | 13,598 |
| 2025-03-03 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise 10b5-1 | +514 | $146.34 | $75K | 14,112 |
| 2025-03-03 | Ghoshal Kaushik Chief Commercial Officer, SaaS | Option exercise 10b5-1 | +4,726 | $211.76 | $1.0M | 18,838 |
Page 9 of 18 · 360 trades